Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Frustrated investor, prove me wrong !
View:
Post by talisman47 on Feb 01, 2021 1:53pm

Frustrated investor, prove me wrong !

The timing of this DMT news release doesn't make sense to me . They could easily have waited thirty days and keep investors focus on Ifenprodil and the data release coming out this month. Wouldn't they want investors to be focused , anxiously waiting for the data news release and have the stock rise in anticipation ?? Now it feels like they aren't as interested as they were with Ifenprodil as they now have a new drug to throw against a wall to see if it sticks ! 

Regardless of ifenprodil, DMT , chronic cough or IPF they are still a small company that can't seem to be able to move their stock past  30 cents.... Chris brags about how much volume  the stock has traded over the last year but where has it gone? In March it was 26 cents, today it is 26 cents. If the stock was actually moving up based on what they were doing everyone would take things more seriously. Why can't they or why don't they want to see the stock move forward......
Comment by Bradwait on Feb 01, 2021 3:15pm
What if talks with a major pharmaceutical company are going so well that they can think ahead in other areas? It's a possibility. If you have high confidence in Ifenprodil then you have to see that AGN is going to have a huge amount added to its market cap soon via a much, much higher share price. To me the risk/reward here looks outstanding.
Comment by talisman47 on Feb 01, 2021 4:08pm
Hopefully, they are having a conversation with a serious Pharma company. Back in December they 'looked under the hood' as Chris said on their interim results to see how data was going. I assume there is nothing stopping them from having lifted under the hood again  in January to see what the final data was trending. If it was great news could they keep it this quiet? Hope so, but as I ...more  
Comment by Danorrn on Feb 01, 2021 4:22pm
If I recall on one of the video talks they said they would be pursuing more opportunities as they continued with ifenprodil. This is just the start. Why do certain people choose to look for anything and everything negative. They're actually keeping a promise. That's a good thing and also a rare thing on the vulture exchange.
Comment by talisman47 on Feb 01, 2021 4:43pm
I agree, pursuing more opportunies are great, however, it just seems "fishy"  that they announce a new product  direction for the company within about three weeks of coming out with the Ifenprodil data results for Covid. They have been working hard on covid related study since March and were always coming out with news releases related to that. Just odd they would throw out a ...more  
Comment by Closure70 on Feb 01, 2021 7:40pm
Not sure if this ies related, a new ETF launched on psychedelic's...not on the listing but may be trying to pisition for the next relevant play.  Realistically, the results come in and of month, why would anyone sit on their hands if there is inherent value to pursue?   https://www.horizonsetfs.com/PSYK#
Comment by TheBearInTheWoods on Feb 01, 2021 8:47pm
oh my chest, is this guy serious lmao  
Comment by AGNPFer on Feb 01, 2021 8:57pm
This post has been removed in accordance with Community Policy
Comment by AGNPFer on Feb 01, 2021 7:51pm
This post has been removed in accordance with Community Policy
Comment by TheBearInTheWoods on Feb 01, 2021 8:56pm
I think you need to respect AGN for the ability to have 140 million shares outstanding and being able to lure in gullible people to hold 1.26. They took a stock from .03 to .56 and raised enough money to pay salaries for a couple years as they start a new venture to start fresh. Cheers to that team, well played on the CSE!!! IMHO  P.S this team halts the stock when Chris orders sushi for ...more  
Comment by AGNPFer on Feb 01, 2021 9:03pm
This post has been removed in accordance with Community Policy
Comment by GObabyGO1 on Feb 01, 2021 10:45pm
Snake oil salesmen doing what they do best. If ifenprodil was a success they would need all hands on deck to roll it out. CLEARLY the results are sh!t and they are playing smoke and mirrors now. The company is a complete joke.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities